Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Biocon announced that its board is scheduled to meet on 4 April 2025 to consider raising funds through issuance of commercial papers (CP) or through any other mode via private placement basis.

Syngene International appoints Peter Bains as MD & CFO. Syngene International announced that its board approved the ...

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.

Shaw posted the video that showed beautiful stone roads in the Ecuador island of San Cristobal and bashed Bengaluru’s ...

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/04/2025 ,inter alia, to consider and approve Intimation of Board meeting for raising funds throu ...

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

Sharing a video of the roads in San Cristobal Island, Ecuador, founder and CEO of Biocon, Kiran Mazumdar-Shaw criticised ...

Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...

Biocon chief Kiran Mazumdar Shaw on Thursday criticised Bengaluru's infrastructure and compared the city's streets to those ...